# Biovie Inc.: Form SCHEDULE 13D, filed Mar 25, 2026

- Company: [Biovie Inc.](/companies/bivi.md) (CIK 1580149)
- Form: SCHEDULE 13D
- Filed: 2026-03-25
- Accepted by EDGAR: Mar 25, 2026, 17:00 ET
- Period: not reported
- Accession: 0001520138-26-000086
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1580149/000152013826000086/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1580149/000152013826000086/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1580149/000152013826000086/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Mar 25, 2026.
Source: SEC EDGAR, the filing index for accession 0001520138-26-000086. Last ingested by Listed: Nov 11, 2026, 03:03 ET. No prices; not investment advice.
